D. E. Shaw & Co., Inc. Iovance Biotherapeutics, Inc. Put Options Transaction History

D. E. Shaw & Co., Inc.

2 transactions

Quarter	Operation	Price Per put	puts change	puts Held	SEC Form
Q1 2024 May 15, 2024	BUY	$7.59 - $17.47 $639,078 - $1.47 Million	84,200 New	84,200 $1.25 Million
Q2 2021 Aug 16, 2021	BUY	$16.33 - $33.07 $498,064 - $1.01 Million	30,500 New	30,500 $794,000

314

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.44B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.